Inhibition of PHA and NaI04 mitogenesis by the adenosine deaminase inhibitors erythro-9-(2-hydroxy-3-nonyl) adenine (EHNA) and 2-deoxycoformycin (2-dCF).
D000225:Adenine / Q000031:analogs & derivatives* / Q000494:pharmacology; D058892:Adenosine Deaminase Inhibitors; D000818:Animals; D002455:Cell Division / Q000187:drug effects; D002470:Cell Survival; D003070:Coformycin / Q000031:analogs & derivatives / Q000494:pharmacology*; D004285:Dogs; D007962:Leukocytes / Q000276:immunology; D051379:Mice; D009700:Nucleoside Deaminases / Q000037:antagonists & inhibitors*; D010504:Periodic Acid / Q000494:pharmacology*; D010835:Phytohemagglutinins / Q000494:pharmacology*; D051381:Rats; D012263:Ribonucleosides / Q000494:pharmacology*
D058892:Adenosine Deaminase Inhibitors; D010835:Phytohemagglutinins; D012263:Ribonucleosides; D010504:Periodic Acid; D003070:Coformycin; D009700:Nucleoside Deaminases; D000225:Adenine